Clinical trial Recruiting at 4 sites Phase 4 Interventional Ages 18 and up

Optimizing treatment for pulmonary edema and heart failure

Official title: Vasodilatation or Loop-Diuretics for Initial Treatment of Pulmonary Congestion Due to Acute Heart Failure - A Randomized Placebo-Controlled Trial

Run by Copenhagen University Hospital, Rigshospitalet · NCT05276219 · Data updated 2026-11-12

This study is testing which treatment works best for people with acute heart failure and pulmonary edema by comparing a diuretic, a vasodilator, and a combination of both.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1041 (estimated)
SponsorCopenhagen University Hospital, Rigshospitalet
Academic / other
Locations5 sites (Copenhagen, Copenhagen and 4 other locations)
StatusRecruiting
StartedSeptember 14, 2023
Main results expectedMay 1, 2027
Study endsMay 1, 2027
Registry record updatedOctober 23, 2026
Trial IDNCT05276219 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who present with acute onset or worsening dyspnea and signs of pulmonary congestion.

Probably not a fit

Patients who have received more than 40 mg of IV furosemide within the last three hours or those with ongoing severe arrhythmias may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of three treatment strategies for pulmonary edema in patients experiencing acute heart failure: intravenous loop-diuretics (furosemide), vasodilation (nitrates), and a combination of both. The study will be conducted in a randomized, double-blinded, placebo-controlled manner, with patients receiving treatment within three hours of hospital admission. The primary objective is to determine which strategy provides superior outcomes in the first six hours of treatment. The trial will include patients with signs of congestion and will evaluate their response to the different treatment approaches.

Why it matters

Potential benefit: If successful, this trial could lead to improved treatment protocols for patients suffering from acute pulmonary edema and heart failure.

How similar studies have gone: While the use of loop-diuretics is well-established, this specific comparison of treatment strategies in a hyperacute setting is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria

1. Age ≥ 18 years
2. Acute (within minutes to days) onset or worsening of subjective dyspnea\*
3. Systolic blood pressure ≥100 mmHg
4. Oxygen saturation \<94% or need of oxygen
5. Signs or suspicion of congestion (peripheral edema, rales, and/or clinical suspicion of congestion) \*

   * by the best assessment from a medical doctor. Inclusion must not wait on x-ray or other measures: patients suspected of pulmonary congestion should be included immediately.

Exclusion criteria

1. More than 50 mg IV furosemide within the last three hours before randomization including prehospital treatment.
2. More than 3 hours from hospital-admission to randomization
3. Ongoing ventricular taky- or brady-arrythmias or supraventricular arrhythmias with HR \> 180 or \< 40 bpm.
4. Suspected severe infection or sepsis.

Exclusion criteria are purposely liberal, so patients can be included in accordance with everyday clinical practice. However, a safety criterion will be implemented:

If blood pressure drops below 90 mmHg in 2 measurements with 5 minutes apart and/or if urine production is below 50 ml after 1 hour, the intervention will be stopped, and patients can receive furosemide and nitrates freely.

We purposely chose not to exclude patients with aortic stenosis, since observational studies did not find excess risk of given nitrates to patients with pulmonary edema and aortic stenosis

Where it's running

  • Bispebjerg Hospital
    Copenhagen, Copenhagen, Denmark
    Recruiting
  • Herlev University Hospital
    Herlev, Denmark
    Recruiting
  • Hvidovre Hospital
    Hvidovre, Denmark
    Recruiting
  • Roskilde Hospital
    Roskilde, Denmark
    Recruiting
  • Nordsjællands Hospital
    Hillerød, Denmark
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.